Cyril O. Spann, MD - Professor
Gynecologic Oncology
Academic Office
Emory University School of Medicine
Department of Gynecology and Obstetrics
Division of Gynecologic Oncology
Glenn Building, 4th Floor
49 Jesse Hill Jr. Drive, SE
Atlanta, GA 30303
Email · cspann@emory.edu
Clinical Office
Emory University Hospital Midtown
Medical Office Tower, 9th Floor
550 Peachtree Street, N.E.
Atlanta, GA 30309
Patient Appointments · 404-778-3401
Dr. Spann received his undergraduate degree from St. Andrews College; after receiving his M.D. degree at Meharry Medical College he matriculated into the Gynecology and Obstetrics residency at Emory University. He served as Chief Administrative Resident during his senior year and decided to stay on as faculty in a teaching role for medical students and residents. He then entered and completed a Gynecologic Oncology fellowship at the University of North Carolina. Dr. Spann completed a Masters degree in health care management at the Harvard University School of Public Health in 2004. His primary instructional role in the department is teaching advanced surgical techniques to residents. He also serves as a surgical consultant to faculty at Grady Memorial Hospital and Crawford Long Hospital. He serves as Chief, Emory Gynecology and Obstetrics Service, Crawford Long Hospital.
Dr. Spann has received numerous teaching awards from residents and medical students. He received the 1997 National Faculty Award for Excellence in Resident Education in Obstetrics and Gynecology and the 1998 Association of Professors of Gynecology and Obstetrics Excellence in Teaching Award. In 1998, he was chosen Best Gynecology-Obstetrics Attending for the third time by the Emory School of Medicine's senior class and has been named Best Attending by the residents numerous times. He has sponsored dozens of Resident Research Day projects and is a mentor for those interested in pursuing fellowship or private practice opportunities. His research focus includes participation in the Gynecologic Oncology Group, placing patients on protocols for various gynecologic malignancies and gynecologic surgery.
Dr. Spann is a Diplomate of the American Board of Obstetrics and Gynecology and currently serves as an examiner for the ABOG oral exams. He is a member of numerous societies including American Association of Gynecologic Endoscopists; Fellow, American College of Obstetricians & Gynecologists; American College of Surgeons; Gynecologic Cancer Foundation (Board of Trustees); National Medical Association; The American Association of Gynecologic Laparoscopists; the American Board of Quality Assurance and Utilization Review Physicians, Inc.; and the Society of Gynecologic Oncologists.
Publications
Spann C: Loop Electrosurgical Excision Procedure and Large Loop Excision of the Transformation Zone in the Treatment of Cervical Intraepithelial Neoplasia. Operative Techniques in Gynecologic Surgery, 1998: 4:114-119.
Thoms WW, Unger ER, Carisio R, Nisenbaum R, Spann CO, Horowitz IR, Reeves WC. Clinical determinants of survival from Stage 1b cervical cancer in an inner-city hospital. Journal of National Medical Association. 1998; 90:303-308.
Unger ER, Vernon SD, Nisenbaum R, Thoms WW, Spann C, Miller DL, Lee DR, Horowitz IR, Icenogle JP, Reeves WC: Human Papillomavirus and disease status following therapy for cervical cancer. Clin Infect Dis, 1998; 26:373-8.
Copas PR, Spann CO, Majmudar B, Horowitz, IR. Basal cell carcinoma of the vulva: A report of four cases. J Reprod Med 1996; 41:283-286.
Unger ER, Vernon SD, Thoms WW, Nisenbaum R, Spann CO, Horowitz IR, Icenogle JP, Reeves WC: Human Papillomavirus and disease-free survival in FIGO State 1B cervical cancer. J infec Dis 1995; 172:1184-90.
Copas PR, Spann CO, Thoms WW, Horowitz IR. Squamous cell carcinoma of the cervix metastatic to a drain site. Gynecol Oncol 1995; 56:102-104.
Copas PR, Spann CO, Majmudar B, Horowitz IR. Basal cell carcinoma secondary to radiotherapy for carcinoma of the cervix. Southern Medical Journal 1995; 88:11:1161-62.
Thoms WW, Unger ER, Johnson PR, Spann CO, Hunter SH, Smith R, Horowitz IR, Icenogle JP, Vernon SD , Reeves WC. Cervical cancer survival in a high risk urban population. Cancer 1995; 76:12:2518-2523.
Copas PR, Spann CO, Lim JI, Horowitz IR. Candidal retinitis in a gynecologic patient: A case report. Infectious Diseases in Obstetrics and Gynecology 1995; 2:228-230.
Horowitz IR, Copas PR, Aaronoff M, Spann CO, McGuire WP. Endometrial adenocarcinoma following endometrial ablation for postmenopausal bleeding. Gynecologic Oncology 1995; 56:460-463.
Spann CO, Kennedy J. Frozen section evaluation of ovarian neoplasms. Journal of National Medical Association 1994;86, 2:141-144.
Spann CO, Kennedy J, Brown T. Value of endocervical curettage at time of cone biopsy. Journal of National Medical Association 1993; 85:117-119.
Maddux HR, Varia MA, Spann CO, Fowler WC, Rosenman JF. Invasive cancer of uterine cervix in patients 25 or less. Int J Rad Onc, Biology and Physics 1990; 9:701.
Book chapters:
Spann CO . Chapter 10: Water, Electrolyte, and Acid-Base Metabolism. Te Linde’s Operative Gynecology, 8th edition, Lippincott-Raven 1997: 165-195.
Spann CO . Chapter 8: Cervical carcinoma. Medicine for the Practicing Physician, 4th edition, Appleton & Lange, 1996: 724-.
Spann CO . Chapter 10: Vaginal Carcinoma. Medicine for the Practicing Physician, 4th edition, Appleton & Lange 1996: 731-.
Other publications
Horowitz IR, Copas PR, Aaronoff M, Spann CO, McGuire WP: Endometrial adenocarcinoma following endometrial ablation for postmenopausal bleeding. The American College of Obstetricians and Gynecologists (ACOG) Current Journal Review. 1995; 8(5):42.
Musoke E, Spann CO, Kennedy JC, Horowitz IR. Postpartum pap smears: Are they really necessary? Gynecol Oncol 1994; 52:150:139.
Thoms WW, Hunter SH, Spann CO , Horowitz IR, Reeves WC. Relation of race and treatment to cervical cancer outcome in a high-risk metropolitan population. Gynecol Oncol 1994; 52:152:140.
Unger ER, Vernon SD, Thoms WW, Spann C, Icenogle JP, Horowitz IR, Reeves WC: Human Papillomarvirus status of genital tract following therapy for cervical cancer. Lab Invest 1994; 70:97A.